View More View Less
  • 1 Guru Nanak Dev University Department of Microbiology Amritsar 143005 India
Restricted access

Purchase article

USD  $25.00

1 year subscription (Individual Only)

USD  $784.00

A wild type Aspergillus terreus GD13 strain, chosen after extensive screening, was optimized for lovastatin production using statistical Box-Behnken design of experiments. The interactive effect of four process parameters, i.e. lactose and soybean meal, inoculum size (spore concentration) and age of the spore culture, on the production of lovastatin was evaluated employing response surface methodology (RSM). The model highlighted the positive effect of soybean meal concentration and inoculum level for achieving maximal level of lovastatin (1342 mg/l). The optimal fermentation conditions improved the lovastatin titre by 7.0-folds when compared to the titres obtained under unoptimized conditions.

  • Adam, O., Laufs, U.: Antioxidative effects of statins. Arch. Toxicol. 82, 885–892 (2008).

    Laufs U. , 'Antioxidative effects of statins ' (2008 ) 82 Arch. Toxicol. : 885 -892.

  • Becker, C., Jick, S. S., Meier, C. R.: Use of statins and the risk of Parkinson’s disease: A retrospective case control study in the UK. Drug Saf. 31, 399–407 (2008).

    Meier C. R. , 'Use of statins and the risk of Parkinson’s disease: A retrospective case control study in the UK ' (2008 ) 31 Drug Saf. : 399 -407.

    • Search Google Scholar
  • Glynn, S. A., O’sullivan, D., Eustace, A. J., Clynes, M., O’Donovan, N.: The 3-hydroxy3methylglutaryl-coenzyme A reductase inhibitors, simvastatin, lovastatin and mevastatin inhibit proliferation and invasion of melanoma cells. BMC Cancer 8:9. DOI 10.118/1471-2407-8-9 (2008).

    O’Donovan N. , 'The 3-hydroxy3methylglutaryl-coenzyme A reductase inhibitors, simvastatin, lovastatin and mevastatin inhibit proliferation and invasion of melanoma cells ' (2008 ) 8 BMC Cancer : 9 -.

    • Search Google Scholar
  • Barrios-Gonzalez, J., Miranda, R. U.: Biotechnological production and applications of statins. Appl. Microbiol. Biotechnol. 85, 869–883 (2010).

    Miranda R. U. , 'Biotechnological production and applications of statins ' (2010 ) 85 Appl. Microbiol. Biotechnol. : 869 -883.

    • Search Google Scholar
  • Varga, J., Toth, B., Kocsube, S., Farkas, B., Szakacs, G., Teren, J., Kozakiewicz, Z.: Evolutionary relationships among Aspergillus terreus isolates and their relatives. Antonie Leeuwenhoek 88, 141–150 (2005).

    Kozakiewicz Z. , 'Evolutionary relationships among Aspergillus terreus isolates and their relatives ' (2005 ) 88 Antonie Leeuwenhoek : 141 -150.

    • Search Google Scholar
  • Shindia, A. A.: Some nutritional factors influencing mevinolin production by Aspergillus terreus strain. Folia Microbiol. 46, 413–416 (2001).

    Shindia A. A. , 'Some nutritional factors influencing mevinolin production by Aspergillus terreus strain ' (2001 ) 46 Folia Microbiol. : 413 -416.

    • Search Google Scholar
  • Casas Lopez, J. L., Sanchez Perez, J. A., Fernandez Sevilla, J. M., Acien Fernandez, F. G., Molina Grima, E., Em Chisti, Y.: Production of lovastatin by Aspergillus terreus: Effects of the C:N ratio and the principal nutrients on growth and metabolite production. Enzyme Microb. Technol. 33, 270–277 (2003).

    Em Chisti Y. , 'Production of lovastatin by Aspergillus terreus: Effects of the C:N ratio and the principal nutrients on growth and metabolite production ' (2003 ) 33 Enzyme Microb. Technol. : 270 -277.

    • Search Google Scholar
  • Casas Lopez, J. L., Sanchez Perez, J. A., Fernandez Sevilla, J. M., Acien Fernandez, F. G., Molina Grima, E., Em Chisti, Y.: Fermentation optimization for the production by Aspergillus terreus: Use of response surface methodology. J. Chem. Technol. Biotechnol. 79, 1119–1126 (2004).

    Em Chisti Y. , 'Fermentation optimization for the production by Aspergillus terreus: Use of response surface methodology ' (2004 ) 79 J. Chem. Technol. Biotechnol. : 1119 -1126.

    • Search Google Scholar
  • Bizukojc, M., Ledakowicz, S.: A macrokinetic modelling of the biosynthesis of lovastatin by Aspergillus terreus. J. Biotechnol. 130, 422–435 (2007).

    Ledakowicz S. , 'A macrokinetic modelling of the biosynthesis of lovastatin by Aspergillus terreus ' (2007 ) 130 J. Biotechnol. : 422 -435.

    • Search Google Scholar
  • Bizukojc, M., Ledakowicz, S.: Physiological, morphological and kinetic aspects of lovastatin biosynthesis by Aspergillus terreus. Biotechnol. J. 4, 647–664 (2009).

    Ledakowicz S. , 'Physiological, morphological and kinetic aspects of lovastatin biosynthesis by Aspergillus terreus ' (2009 ) 4 Biotechnol. J. : 647 -664.

    • Search Google Scholar
  • Novak, N., Gerdin, S., Berovic, M.: Increased lovastatin formation by Aspergillus terreus using repeated fed-batch process. Biotechnol. Lett. 19, 947–948 (1997).

    Berovic M. , 'Increased lovastatin formation by Aspergillus terreus using repeated fed-batch process ' (1997 ) 19 Biotechnol. Lett. : 947 -948.

    • Search Google Scholar
  • Casas Lopez, J. L., Sanchez Perez, J. A., Fernandez Sevilla, J. M., Rodriguez Porcel, E. M., Chisti, Y.: Pellet morphology, culture rheology and lovastatin production in cultures of Aspergillus terreus. J. Biotech. 116, 61–77 (2005).

    Chisti Y. , 'Pellet morphology, culture rheology and lovastatin production in cultures of Aspergillus terreus ' (2005 ) 116 J. Biotech. : 61 -77.

    • Search Google Scholar
  • Lai, L. S. T., Tsai, T. H., Wang, T. C., Cheng, T. Y.: The influence of culturing environments on lovastatin production by Aspergillus terreus in submerged cultures. Enzyme Microb. Technol. 36, 737–748 (2005).

    Cheng T. Y. , 'The influence of culturing environments on lovastatin production by Aspergillus terreus in submerged cultures ' (2005 ) 36 Enzyme Microb. Technol. : 737 -748.

    • Search Google Scholar
  • Rodriguez-Porcel, E., Casas-Lopez, J. L., Vilches-Ferron, M. A., Sanchez-Perez, J. A., Garcia-Sanchez, Chisti, Y.: Effects of the sporulation conditions on the lovastatin production by Aspergillus terreus. Bioprocess Biosyst Eng DOI 10.1007/s0049-006-0048-1 (2006).

  • Jia, Z., Zhang, X., Zhao, Y., Cao, X.: Effect of divalent metal cations on lovastatin biosynthesis from Aspergillus terreus in chemically defined medium. World J. Microbiol. Biotechnol. 25, 1235–1241 (2009).

    Cao X. , 'Effect of divalent metal cations on lovastatin biosynthesis from Aspergillus terreus in chemically defined medium ' (2009 ) 25 World J. Microbiol. Biotechnol. : 1235 -1241.

    • Search Google Scholar
  • Kumar, M. S., Jana, S. K., Senthil, V., Shashanka, V., Kumar, S. V., Sadhukhan, A. K.: Repeated fed-batch process for improving lovastatin production. Process Biochem. 36, 363–368 (2000).

    Sadhukhan A. K. , 'Repeated fed-batch process for improving lovastatin production ' (2000 ) 36 Process Biochem. : 363 -368.

    • Search Google Scholar
  • Lai, L. S. T., Pan, C. C., Tzeng, B-K.: The influence of medium design on lovastatin production and pellet formation with a high-producing mutant of Aspergillus terreus in submerged cultures. Process Biochem. 38, 1317–1326 (2003).

    Tzeng B.-K. , 'The influence of medium design on lovastatin production and pellet formation with a high-producing mutant of Aspergillus terreus in submerged cultures ' (2003 ) 38 Process Biochem. : 1317 -1326.

    • Search Google Scholar
  • Gupta, K., Mishra, P. K., Srivastava, P.: Enhanced continuous production of lovastatin using pellets and siran supported growth of Aspergillus terreus in an airlift reactor. Biotechnol. Bioprocess Eng. 14, 207–212 (2009).

    Srivastava P. , 'Enhanced continuous production of lovastatin using pellets and siran supported growth of Aspergillus terreus in an airlift reactor ' (2009 ) 14 Biotechnol. Bioprocess Eng. : 207 -212.

    • Search Google Scholar
  • Kaur, H., Kaur, A., Chadha, B. S.: Screening and selection of lovastatin hyper-producing mutants of Aspergillus terreus using cyclic mutagenesis. Acta Microbiol. et Immunol. Hung. 56, 167–178 (2009).

    Chadha B. S. , 'Screening and selection of lovastatin hyper-producing mutants of Aspergillus terreus using cyclic mutagenesis ' (2009 ) 56 Acta Microbiol. et Immunol. Hung. : 167 -178.

    • Search Google Scholar
  • Casas Lopez, J. L., Rodriguez Porcel, E. M., Vilches Ferron, M. A., Sanchez Perez, J. A., Fernandez Sevilla, J. M., Chisti, Y.: Lovastatin inhibits its own synthesis in Aspergillus terreus. J. Ind. Microbiol. Biotechnol. 31, 48–50 (2004).

    Chisti Y. , 'Lovastatin inhibits its own synthesis in Aspergillus terreus ' (2004 ) 31 J. Ind. Microbiol. Biotechnol. : 48 -50.

    • Search Google Scholar
  • Szakacs, G., Morovjan, G., Tengerdy, R. P.: Production of lovastatin by a wild strain of Aspergillus terreus. Biotechnol. Lett. 20, 411–415 (1998).

    Tengerdy R. P. , 'Production of lovastatin by a wild strain of Aspergillus terreus ' (1998 ) 20 Biotechnol. Lett. : 411 -415.

    • Search Google Scholar
  • Hajjaj, H., Niederberger, P., Duboe, P.: Lovastatin biosynthesis by Aspergillus terreus in a chemically defined medium. Appl. Environ. Microbiol. 67, 2596–2602 (2001).

    Duboe P. , 'Lovastatin biosynthesis by Aspergillus terreus in a chemically defined medium ' (2001 ) 67 Appl. Environ. Microbiol. : 2596 -2602.

    • Search Google Scholar
  • Panda, B. P., Javed, S., Ali, M.: Optimization of fermentation parameters for higher lovastatin production in red mold rice through co-culture of Monascus purpureus and Monascus ruber. Food Bioprocess Technol DOI 10.1007/s 11947-008-0072-z (2008).

  • Wang, J. J., Lee, C-L., Pan, T-M.: Improvement of monacolin K, γ-aminobutyric acid and citrinin production ratio as a function of environmental conditions of Monascus purpureus NTU 601. J. Ind. Microbiol. Biotechnol. 30, 669–676 (2003).

    Pan T.-M. , 'Improvement of monacolin K, γ-aminobutyric acid and citrinin production ratio as a function of environmental conditions of Monascus purpureus NTU 601 ' (2003 ) 30 J. Ind. Microbiol. Biotechnol. : 669 -676.

    • Search Google Scholar
  • Chang, Y. N., Lin, Y. C., Lee, C. C., Liu, B. L., Tzeng, Y. M.: Effect of rice-glycerol complex medium on the production of lovastatin by Monascus ruber. Folia Microbiol. 47, 677–684 (2002).

    Tzeng Y. M. , 'Effect of rice-glycerol complex medium on the production of lovastatin by Monascus ruber ' (2002 ) 47 Folia Microbiol : 677 -684.

    • Search Google Scholar
  • Manzoni, M., Bergomi, S., Rollini, M., Cavazzoni, V.: Production of statins by filamentous fungi. Biotechnol. Lett. 21, 253–257 (1999).

    Cavazzoni V. , 'Production of statins by filamentous fungi ' (1999 ) 21 Biotechnol. Lett. : 253 -257.

    • Search Google Scholar
  • Miyake, T., Uchitomi, K., Zhang, M. Y., Kono, I., Nozaki, N., Sammoto, H., Inagaki, K.: Effects of the principal nutrients on lovastatin production by Monascus pilosus. Biosci. Biotechnol. Biochem. 70, 1154–1159 (2006).

    Inagaki K. , 'Effects of the principal nutrients on lovastatin production by Monascus pilosus ' (2006 ) 70 Biosci. Biotechnol. Biochem. : 1154 -1159.

    • Search Google Scholar

 

The author instruction is available in PDF.
Please, download the file from HERE

Senior editors

Editor-in-Chief: Prof. Dóra Szabó (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Managing Editor: Dr. Béla Kocsis (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Co-editor: Dr. Andrea Horváth (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Editorial Board

  • Prof. Éva ÁDÁM (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Sebastian AMYES (Department of Medical Microbiology, University of Edinburgh, Edinburgh, UK.)
  • Dr. Katalin BURIÁN (Institute of Clinical Microbiology University of Szeged, Szeged, Hungary; Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary.)
  • Dr. Orsolya DOBAY (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Ildikó Rita DUNAY (Institute of Inflammation and Neurodegeneration, Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany; Center for Behavioral Brain Sciences (CBBS), Magdeburg, Germany)
  • Prof. Levente EMŐDY(Department of Medical Microbiology and Immunology, University of Pécs, Pécs, Hungary.)
  • Prof. Anna ERDEI (Department of Immunology, Eötvös Loránd University, Budapest, Hungary, MTA-ELTE Immunology Research Group, Eötvös Loránd University, Budapest, Hungary.)
  • Prof. Éva Mária FENYŐ (Division of Medical Microbiology, University of Lund, Lund, Sweden)
  • Prof. László FODOR (Department of Microbiology and Infectious Diseases, University of Veterinary Medicine, Budapest, Hungary)
  • Prof. József KÓNYA (Department of Medical Microbiology, University of Debrecen, Debrecen, Hungary)
  • Prof. Yvette MÁNDI (Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary)
  • Prof. Károly MÁRIALIGETI (Department of Microbiology, Eötvös Loránd University, Budapest, Hungary)
  • Prof. János MINÁROVITS (Department of Oral Biology and Experimental Dental Research, University of Szeged, Szeged, Hungary)
  • Prof. Béla NAGY (Centre for Agricultural Research, Institute for Veterinary Medical Research, Budapest, Hungary.)
  • Prof. István NÁSZ (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Kristóf NÉKÁM (Hospital of the Hospitaller Brothers in Buda, Budapest, Hungary.)
  • Dr. Eszter OSTORHÁZI (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Rozália PUSZTAI (Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary)
  • Prof. Peter L. RÁDY (Department of Dermatology, University of Texas, Houston, Texas, USA)
  • Prof. Éva RAJNAVÖLGYI (Department of Immunology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary)
  • Prof. Ferenc ROZGONYI (Institute of Laboratory Medicine, Semmelweis University, Budapest, Hungary)
  • Prof. Zsuzsanna SCHAFF (2nd Department of Pathology, Semmelweis University, Budapest, Hungary)
  • Prof. Joseph G. SINKOVICS (The Cancer Institute, St. Joseph’s Hospital, Tampa, Florida, USA)
  • Prof. Júlia SZEKERES (Department of Medical Biology, University of Pécs, Pécs, Hungary.)
  • Prof. Mária TAKÁCS (National Reference Laboratory for Viral Zoonoses, National Public Health Center, Budapest, Hungary.)
  • Prof. Edit URBÁN (Department of Medical Microbiology and Immunology University of Pécs, Pécs, Hungary; Institute of Translational Medicine, University of Pécs, Pécs, Hungary.)

 

Editorial Office:
Akadémiai Kiadó Zrt.
Budafoki út 187-187, A/3, H-1117 Budapest, Hungary

Editorial Correspondence:
Acta Microbiologica et Immunologica Hungarica
Institute of Medical Microbiology
Semmelweis University
P.O. Box 370
H-1445 Budapest, Hungary
Phone: + 36 1 459 1500 ext. 56101
Fax: (36 1) 210 2959
E-mail: amih@med.semmelweis-univ.hu

 Indexing and Abstracting Services:

  • Biological Abstracts
  • BIOSIS Previews
  • CAB Abstracts
  • Chemical Abstracts
  • Global Health
  • Index Medicus
  • Index Veterinarius
  • Medline
  • Referativnyi Zhurnal
  • SCOPUS
  • Science Citation Index Expanded
2020  
Total Cites 662
WoS
Journal
Impact Factor
2,048
Rank by Immunology 145/162(Q4)
Impact Factor Microbiology 118/137 (Q4)
Impact Factor 1,904
without
Journal Self Cites
5 Year 0,671
Impact Factor
Journal  0,38
Citation Indicator  
Rank by Journal  Immunology 146/174 (Q4)
Citation Indicator  Microbiology 120/142 (Q4)
Citable 42
Items
Total 40
Articles
Total 2
Reviews
Scimago 28
H-index
Scimago 0,439
Journal Rank
Scimago Immunology and Microbiology (miscellaneous) Q4
Quartile Score Medicine (miscellaneous) Q3
Scopus 438/167=2,6
Scite Score  
Scopus General Immunology and Microbiology 31/45 (Q3)
Scite Score Rank  
Scopus 0,760
SNIP
Days from  225
sumbission
to acceptance
Days from  118
acceptance
to publication
Acceptance 19%
Rate

2019  
Total Cites
WoS
485
Impact Factor 1,086
Impact Factor
without
Journal Self Cites
0,864
5 Year
Impact Factor
1,233
Immediacy
Index
0,286
Citable
Items
42
Total
Articles
40
Total
Reviews
2
Cited
Half-Life
5,8
Citing
Half-Life
7,7
Eigenfactor
Score
0,00059
Article Influence
Score
0,246
% Articles
in
Citable Items
95,24
Normalized
Eigenfactor
0,07317
Average
IF
Percentile
7,690
Scimago
H-index
27
Scimago
Journal Rank
0,352
Scopus
Scite Score
320/161=2
Scopus
Scite Score Rank
General Immunology and Microbiology 35/45 (Q4)
Scopus
SNIP
0,492
Acceptance
Rate
16%

 

Acta Microbiologica et Immunologica Hungarica
Publication Model Online only Hybrid
Submission Fee none
Article Processing Charge 1100 EUR/article
Regional discounts on country of the funding agency World Bank Lower-middle-income economies: 50%
World Bank Low-income economies: 100%
Further Discounts Editorial Board / Advisory Board members: 50%
Corresponding authors, affiliated to an EISZ member institution subscribing to the journal package of Akadémiai Kiadó: 100%
Subscription Information Online subsscription: 652 EUR / 812 USD
Online subscribers are entitled access to all back issues published by Akadémiai Kiadó for each title for the duration of the subscription, as well as Online First content for the subscribed content.
Purchase per Title Individual articles are sold on the displayed price.

Acta Microbiologica et Immunologica Hungarica
Language English
Size A4
Year of
Foundation
1954
Publication
Programme
2021 Volume 68
Volumes
per Year
1
Issues
per Year
4
Founder Magyar Tudományos Akadémia
Founder's
Address
H-1051 Budapest, Hungary, Széchenyi István tér 9.
Publisher Akadémiai Kiadó
Publisher's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Responsible
Publisher
Chief Executive Officer, Akadémiai Kiadó
ISSN 1217-8950 (Print)
ISSN 1588-2640 (Online)

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
Feb 2021 4 0 0
Mar 2021 2 0 0
Apr 2021 2 0 0
May 2021 1 0 0
Jun 2021 1 0 0
Jul 2021 0 0 0
Aug 2021 0 0 0